Perspective Therapeutics (CATX) Total Liabilities (2011 - 2026)

Perspective Therapeutics' Total Liabilities history runs 16 years deep, the most recent figure standing at $63.3 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 41.67% year-over-year to $63.3 million; the TTM figure through Mar 2026 stood at $63.3 million (up 41.67% YoY), while the FY2025 annual figure was $59.9 million, up 18.85% from the prior year.
• Total Liabilities came in at $63.3 million for Q1 2026 at Perspective Therapeutics, up from $59.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $63.3 million in Q1 2026 to a low of $2.9 million in Q1 2022.
• A 5-year average of $31.9 million and a median of $44.7 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 558.51% in 2023 and declined 16.07% in 2025, its largest moves.
• Perspective Therapeutics' Total Liabilities stood at $3.4 million in 2022, then surged by 558.51% to $22.7 million in 2023, then jumped by 122.05% to $50.4 million in 2024, then gained by 18.85% to $59.9 million in 2025, then rose by 5.66% to $63.3 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $63.3 million, $59.9 million, and $52.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison